查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599623

女性健康市場：按年齡、分銷管道和應用分類 - 全球預測 2025-2030

Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年女性健康市場價值為432.3億美元，預計到2024年將達到469.9億美元，複合年成長率為8.97%，到2030年將達到789億美元。

女性健康市場包括廣泛的產品和服務，旨在滿足女性整個生命階段的獨特健康需求。此細分市場包括針對生殖健康、更年期、骨質疏鬆症和營養缺乏等領域的藥品、醫療設備、健康產品、診斷和整體健康服務。女性的健康需求植根於影響乳癌、婦科疾病和心理健康等疾病的獨特生物和荷爾蒙因素，這些因素需要專門的產品和治療。該市場由醫療機構、居家照護和專科診所的應用推動，滿足包括少女、年輕女性、孕婦和老年人在內的廣泛最終用戶的需求。影響市場成長的主要因素包括慢性病盛行率的上升、醫療保健意識的提高以及醫療保健服務的技術進步。

主要市場統計
基準年[2023] 432.3億美元
預測年份 [2024] 469.9億美元
預測年份 [2030] 789億美元
複合年成長率（%） 8.97%

隨著女性人口老化以及人們對預防性醫療保健的日益重視，個人化醫療和遠端醫療面臨著巨大的機會。公司可以透過投資人工智慧主導的診斷和穿戴式健康追蹤器來利用這些趨勢。此外，向天然和有機健康解決方案的轉變為創新提供了成長空間。然而，市場面臨嚴格的法規環境、高昂的研發成本以及限制獲得醫療保健的社會經濟差異等挑戰。

最佳創新領域包括開發個人化、非侵入性診斷工具，特別是針對荷爾蒙和生殖系統疾病的診斷工具，以及提高患者參與度和護理連續性的數位健康解決方案。市場是動態的，需要隨著消費者偏好的變化和法規的變化而不斷適應和研究。企業應注重夥伴關係和協作，以促進創新並提高市場滲透率。提高婦女的健康素養、填補知識空白和支持知情決策也很重要。為了實現永續成長，公司應積極解決女性健康解決方案的可近性和可負擔性問題，以滿足不同社會經濟群體的需求。

市場動態：揭示快速發展的女性健康市場的關鍵市場洞察

供需的動態交互作用正在改變女性健康市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 女性荷爾蒙失衡與慢性病增加
    • 超級食品趨勢不斷發展，女性綜合維他命的供應增加
    • 女性對天然食品和植物來源食品的偏好
  • 市場限制因素
    • 臨床治療費用上漲
  • 市場機會
    • 活性化研發活動以開發荷爾蒙失調治療藥物
    • 世界各國政府為改善婦女健康所推出的有利政策
  • 市場挑戰
    • 與藥物攝取相關的副作用

波特五力：駕馭女性健康市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解女性健康市場的外部影響

外部宏觀環境因素對女性健康市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解女性健康市場的競爭格局

對女性健康市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣供應商在女性健康市場的績效評估

FPNV定位矩陣是評估女性健康市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪女性健康市場的成功之路

對於希望加強在全球市場的影響力的公司來說，女性健康市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 女性荷爾蒙失調和慢性疾病增加
      • 超級食品的流行趨勢和女性綜合維他命供應的增加
      • 女性對天然和植物來源補充品的趨勢
    • 抑制因素
      • 臨床治療費用高
    • 機會
      • 活性化旨在開發荷爾蒙失調治療藥物的研發活動
      • 世界各國政府為改善婦女健康推出了有利政策
    • 任務
      • 與藥物攝取相關的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依年齡分類的女性健康市場

  • 13-17歲
  • 18-35歲
  • 36歲以上

第7章 女性保健品市場：依通路分類

  • 醫院
  • 線上
  • 零售

第8章 女性健康市場：依應用分類

  • 避孕藥
  • 子宮內膜異位症和子宮肌瘤
  • 荷爾蒙不孕症
  • 閉經
  • 卵巢症候群
  • 停經後骨質疏鬆症

第9章美洲女性健康市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太女性健康市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲女性保健市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 女性健康Start-UpsIron Health 斥資 450 萬美元成立。
    • Onsite Women's Health 和 Volpara Health 宣佈建立全國夥伴關係。
    • Kiran Mazumdar Shaw 投資女性健康平台 Gytree.com。
    • Bharat Serums and Vaccines 收購了 Firstline Pharma and Genomics，以擴大其在女性健康領域的影響力。
    • Unified Women's Healthcare 收購更年期護理平台 Gennev。
    • 凱雷和 PAI 投資於女性醫療保健。
    • Myovant Sciences 和輝瑞公司的 MYFEMBREE 已獲得美國FDA核准，這是一種每日一次的治療方法，用於治療與子宮內膜異位症相關的中度至重度疼痛。
    • FemTec Health 收購 Nutrimedy，為其女性健康套件增添個人化營養功能。
    • HempStreet 宣布與 Gynica 建立策略夥伴關係。
    • Organon 計劃大幅擴大荷蘭長期避孕藥具的生產。
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AbbVie Inc.
  • Agile Therapeutics, Inc.
  • Alembic Pharmaceuticals Ltd.
  • Amgen Inc.
  • Apothecus Pharmaceutical Corp.
  • Ar-Ex Laboratories Pvt. Ltd.
  • AstraZeneca PLC
  • AVA Sciences by FemTec Health Inc.
  • Bayer AG
  • Bharat Serums and Vaccines Ltd.
  • Boston Imaging
  • Cipla Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Ferring BV
  • GE HealthCare
  • Gennev, Inc. by Unified Women's Healthcare
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mira by Quanovate Tech Inc.
  • Mylan NV by Viatris
  • Novartis AG
  • Pfizer, Inc.
  • Pregna International Ltd.
  • Quest Diagnostics Incorporated
  • Serum Institute Of India Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Sysmex Asia Pacific Pte Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • The Himalaya Drug Company
  • TherapeuticsMD, Inc.
  • Thermo Fisher Scientific Inc.
  • Torrent Pharmaceuticals Ltd.
  • Triglobal Lifesciences（opc）Pvt. Ltd.
Product Code: MRR-434CCDA04E3D

The Women's Health Market was valued at USD 43.23 billion in 2023, expected to reach USD 46.99 billion in 2024, and is projected to grow at a CAGR of 8.97%, to USD 78.90 billion by 2030.

The women's health market encompasses a broad range of products and services aimed at addressing the unique health needs of women throughout their life stages. This sector includes pharmaceuticals, medical devices, wellness products, diagnostics, and holistic health services targeting areas such as reproductive health, menopause, osteoporosis, and nutritional deficiencies. The necessity of women's health is rooted in the distinct biological and hormonal factors influencing conditions like breast cancer, gynecological disorders, and mental health, thereby necessitating specialized products and treatments. The market is driven by applications in healthcare facilities, homecare, and specialized clinics, catering to an expansive end-users demographic, including teenage girls, young women, pregnant women, and seniors. Key factors influencing market growth include the rising incidence of chronic conditions, increasing healthcare awareness, and technological advancements in healthcare delivery.

KEY MARKET STATISTICS
Base Year [2023] USD 43.23 billion
Estimated Year [2024] USD 46.99 billion
Forecast Year [2030] USD 78.90 billion
CAGR (%) 8.97%

With the aging female population and increasing emphasis on preventive healthcare, significant opportunities lie in personalized medicine and digital health solutions like telemedicine platforms. Companies can capitalize on these trends by investing in AI-driven diagnostics and wearable health trackers. Additionally, the shift towards natural and organic health solutions offers a growing space for innovation. However, the market faces challenges such as stringent regulatory environments, high research and development costs, and socio-economic disparities limiting access to healthcare.

The best areas for innovation include the development of personalized, non-invasive diagnostic tools, especially for hormonal and reproductive disorders, and the integration of digital health solutions to enhance patient engagement and care continuity. The market is dynamic, with shifting consumer preferences and regulatory changes, necessitating continuous adaptation and research. Companies should focus on partnerships and collaborations to foster innovation and improve market penetration. It's also critical to enhance health literacy among women, bridging the knowledge gap to aid informed decision-making. For sustained growth, companies should proactively address the accessibility and affordability of women's health solutions, ensuring they cater to diverse socio-economic groups.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Women's Health Market

The Women's Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of hormonal imbalances and chronic diseases in women
    • Rising trend of superfood and increasing availability of multivitamins for women
    • Inclination of women towards natural and plant based health supplements
  • Market Restraints
    • High cost of clinical treatments
  • Market Opportunities
    • Rising R&D activities for drug development to treat the hormonal disorders
    • Favorable policies initiated by governments worlwide to improve women's health
  • Market Challenges
    • Side-effects associated with consumption of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Women's Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Women's Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Women's Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Women's Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Women's Health Market

A detailed market share analysis in the Women's Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Women's Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Women's Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Women's Health Market

A strategic analysis of the Women's Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women's Health Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agile Therapeutics, Inc., Alembic Pharmaceuticals Ltd., Amgen Inc., Apothecus Pharmaceutical Corp., Ar-Ex Laboratories Pvt. Ltd., AstraZeneca PLC, AVA Sciences by FemTec Health Inc., Bayer AG, Bharat Serums and Vaccines Ltd., Boston Imaging, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Ferring B.V., GE HealthCare, Gennev, Inc. by Unified Women's Healthcare, Hologic, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mira by Quanovate Tech Inc., Mylan N.V. by Viatris, Novartis AG, Pfizer, Inc., Pregna International Ltd., Quest Diagnostics Incorporated, Serum Institute Of India Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Asia Pacific Pte Ltd., Teva Pharmaceutical Industries Ltd., The Himalaya Drug Company, TherapeuticsMD, Inc., Thermo Fisher Scientific Inc., Torrent Pharmaceuticals Ltd., and Triglobal Lifesciences (opc) Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Women's Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Age, market is studied across 13-17 Years, 18-35 Years, and 36 Years & Above.
  • Based on Distribution Channel, market is studied across Hospital, Online, and Retail.
  • Based on Application, market is studied across Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome, and Postmenopausal Osteoporosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
      • 5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
      • 5.1.1.3. Inclination of women towards natural and plant based health supplements
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
      • 5.1.3.2. Favorable policies initiated by governments worlwide to improve women's health
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects associated with consumption of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Women's Health Market, by Age

  • 6.1. Introduction
  • 6.2. 13-17 Years
  • 6.3. 18-35 Years
  • 6.4. 36 Years & Above

7. Women's Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Online
  • 7.4. Retail

8. Women's Health Market, by Application

  • 8.1. Introduction
  • 8.2. Contraceptives
  • 8.3. Endometriosis & Uterine Fibroids
  • 8.4. Hormonal Infertility
  • 8.5. Menopause
  • 8.6. Polycystic Ovary Syndrome
  • 8.7. Postmenopausal Osteoporosis

9. Americas Women's Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Women's health startup Iron Health launches with $4.5M.
    • 12.3.2. Onsite Women's Health and Volpara Health Announce National Partnership.
    • 12.3.3. Kiran Mazumdar Shaw invests in women's health platform Gytree.com.
    • 12.3.4. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women's health segment.
    • 12.3.5. Unified Women's Healthcare acquires menopause care platform Gennev.
    • 12.3.6. Carlyle and PAI on women's healthcare.
    • 12.3.7. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
    • 12.3.8. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
    • 12.3.9. HempStreet announces strategic partnership with Gynica.
    • 12.3.10. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AbbVie Inc.
  • 3. Agile Therapeutics, Inc.
  • 4. Alembic Pharmaceuticals Ltd.
  • 5. Amgen Inc.
  • 6. Apothecus Pharmaceutical Corp.
  • 7. Ar-Ex Laboratories Pvt. Ltd.
  • 8. AstraZeneca PLC
  • 9. AVA Sciences by FemTec Health Inc.
  • 10. Bayer AG
  • 11. Bharat Serums and Vaccines Ltd.
  • 12. Boston Imaging
  • 13. Cipla Limited
  • 14. Eli Lilly and Company
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. Ferring B.V.
  • 17. GE HealthCare
  • 18. Gennev, Inc. by Unified Women's Healthcare
  • 19. Hologic, Inc.
  • 20. Johnson & Johnson Services, Inc.
  • 21. Lupin Limited
  • 22. Mankind Pharma Ltd.
  • 23. Mira by Quanovate Tech Inc.
  • 24. Mylan N.V. by Viatris
  • 25. Novartis AG
  • 26. Pfizer, Inc.
  • 27. Pregna International Ltd.
  • 28. Quest Diagnostics Incorporated
  • 29. Serum Institute Of India Ltd.
  • 30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 31. Siemens AG
  • 32. Sysmex Asia Pacific Pte Ltd.
  • 33. Teva Pharmaceutical Industries Ltd.
  • 34. The Himalaya Drug Company
  • 35. TherapeuticsMD, Inc.
  • 36. Thermo Fisher Scientific Inc.
  • 37. Torrent Pharmaceuticals Ltd.
  • 38. Triglobal Lifesciences (opc) Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 13-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 36 YEARS & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ENDOMETRIOSIS & UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POSTMENOPAUSAL OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023